Filing Flows › Arcutis Biotherapeutics (ARQT) › Free cash flow
Arcutis Biotherapeutics (ARQT) free cash flow by quarter
Arcutis Biotherapeutics' free cash flow was $18.8M in Q3 2026 (third quarter 2026), +51% from Q2 2026. Over the last 3 quarters it ranged from $246K (Q2 2025) to $18.8M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $18.8M | +51% | — |
| Q2 2026 | $12.5M | 51× | 51× |
| Q2 2025 | $246K | — | — |
Q3 2026 at a glance
Arcutis Biotherapeutics, Q3 2026: revenue $144M (+45% year over year), operating margin 6.6%, net earnings $8.8M, operating cash flow $18.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arcutis Biotherapeutics' free cash flow?
Arcutis Biotherapeutics' free cash flow was $18.8M in Q3 2026 (third quarter 2026), +51% from Q2 2026.
How has Arcutis Biotherapeutics' free cash flow changed?
Over the last 3 quarters it ranged from $246K (Q2 2025) to $18.8M (Q3 2026).
Q3 2026 results → · How Arcutis Biotherapeutics makes money →